Influence of Decitabine on Demethylation of P15INK4B Gene and the Growth and Apoptosis of Burkitt Lymphoma Raji Cells

被引:1
作者
Liu Qiao [1 ]
机构
[1] Chenzhou 1 Peoples Hosp, Dept Pharm, Chenzhou 423000, Hunan, Peoples R China
来源
JOURNAL OF INTERNATIONAL TRANSLATIONAL MEDICINE | 2014年 / 2卷 / 04期
关键词
Lymphoma; P15INK4B; Decitabine; Methylation; Demethylation; Tumor-suppressor genes;
D O I
10.11910/2227-6394.2014.02.04.07
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective: To explore the methylation status of P15INK4B gene and the biochemical influence of decitabine on the demethylation of P15INK4B gene and the growth and apoptosis of Burkitt lymphoma Raji cells. Methods: Trypan blue was used to test the effects of different concentrations of decitabine on cell growth curve of Burkitt lymphoma Rajj cells. Cell apoptostic rate was detected by flow cytometry (FCM). The expression of P15INK4B gene was detected by reverse transcription-polymerase chain reaction (RT-PCR) and the degree of methylation of P15INK4B gene by methylation-specific PCR (MSP). Results: Different concentrations of decitabine had an inhibiting effect on the proliferation of Raji cells, and promote the apoptosis of Raji cells. After 48-h treatment of decitabine, the mRNA expression of P15INK4B gene of Raji cells was up-regulated in a dose-dependent manner by inducing the demethylation of P15INK4B gene. Conclusion: There exists hypermethylated P15INK4B gene in Burkitt lymphoma Raji cells which makes P15INK4B gene down-regulated. However, decitabine can up-regulate the mRNA expression of P15INK4B gene through inducing the demethylation of P15INK4B gene, thus inhibiting the proliferation of lymphoma Raji cells.
引用
收藏
页码:457 / 461
页数:5
相关论文
共 21 条
  • [1] Loss of p15INK4b Expression in colorectal cancer is Linked to Ethnic Origin
    Abdel-Rahman, Wael Mohamed
    Nieminen, Taina Tuulikki
    Shoman, Soheir
    Eissa, Saad
    Peltomaki, Paivi
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (05) : 2083 - 2087
  • [2] Safety and clinical activity of 5-aza-2′-deoxycytidine (decitabine) with or without Hyper-CVAD in relapsed/refractory acute lymphocytic leukaemia
    Benton, Christopher B.
    Thomas, Deborah A.
    Yang, Hui
    Ravandi, Farhad
    Rytting, Michael
    O'Brien, Susan
    Franklin, Anna R.
    Borthakur, Gautam
    Dara, Samuel
    Kwari, Monica
    Pierce, Sherry R.
    Jabbour, Elias
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2014, 167 (03) : 356 - 365
  • [3] DNA methylation profiling in the Carolina Breast Cancer Study defines cancer subclasses differing in clinicopathologic characteristics and survival
    Conway, Kathleen
    Edmiston, Sharon N.
    May, Ryan
    Kuan, Pei Fen
    Chu, Haitao
    Bryant, Christopher
    Tse, Chiu-Kit
    Swift-Scanlan, Theresa
    Geradts, Joseph
    Troester, Melissa A.
    Millikan, Robert C.
    [J]. BREAST CANCER RESEARCH, 2014, 16 (05)
  • [4] Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2′-deoxycytidine (decitabine) treatment
    Daskalakis, M
    Nguyen, TT
    Nguyen, C
    Guldberg, P
    Köhler, G
    Wijermans, P
    Jones, PA
    Lübbert, M
    [J]. BLOOD, 2002, 100 (08) : 2957 - 2964
  • [5] Dong HY, 2004, J EXP HEMOTOL, V12, P467
  • [6] Duong VH, 2014, LEUKEMIA LYMPHOMA, V27, P1
  • [7] He J, 2014, LEUKEMIA LYMPHOMA, V7, P1
  • [8] Demethylating Agents in the Treatment of Cancer
    Howell, Paul M., Jr.
    Liu, Zixing
    Khong, Hung T.
    [J]. PHARMACEUTICALS, 2010, 3 (07): : 2022 - 2044
  • [9] Brief Report: Loss of p15Ink4b Accelerates Development of Myeloid Neoplasms in Nup98-HoxD13 Transgenic Mice
    Humeniuk, Rita
    Koller, Richard
    Bies, Juraj
    Aplan, Peter
    Wolff, Linda
    [J]. STEM CELLS, 2014, 32 (05) : 1361 - 1366
  • [10] Jabbour E, 2014, LEUKEMIA LYMPHOMA, V17, P1